Bayer presents positive data at ISTH 2020 from its first-in-human Factor VIII gene therapy study in hemophilia A

Monday, July 13, 2020

New data to be presented at the ISTH 2020 Virtual Congress demonstrating Octapharma’s commitment to patients with bleeding disorders

Monday, July 13, 2020

New data from phase IIIb study reinforces safety profile of Roche's Hemlibra in people with haemophilia A

Monday, July 13, 2020

Takeda Provides Updates on Its Pharmacokinetic-guided Prophylaxis Studies at ISTH 2020, Reinforcing Its Commitment to Advancing Personalized Care for People with Bleeding Disorders

Saturday, July 11, 2020

VarmX raises €32 million in Series B financing to develop innovative reversal agent for the treatment and prevention of severe bleeding in patients on oral anticoagulants

Thursday, July 9, 2020

RSS

STAY UPDATED

By submitting this form, you are granting: The International Society on Thrombosis and Haemostasis, 610 Jones Ferry Road, Suite 205 Carrboro, North Carolina 27510 USA, http://www.isth.org permission to email you. You may unsubscribe via the link found at the bottom of every email. (See our Email Privacy Policy for details.) Emails are serviced by Mailchimp.